First Edition: November 2, 2009

Today's headlines feature insights into President Obama's behind-the-scenes role in advancing the Democrats' health overhaul efforts in Congress, plus more analysis of the public insurance option.  

Analysis: Public Option Might Play Only Minor Role In Changing Health Care For all the controversy over a government-run insurance option, the program outlined in health overhaul legislation likely would play a minuscule role in efforts to expand health care coverage, according to many health care experts and lawmakers (Kaiser Health News).

Obama Strategy On Health Care Legislation Appears To Be Paying Off After months of plodding work by five Congressional committees and weeks of back-room bargaining by Democratic leaders, President Obama's arms-length strategy on health care appears to be paying dividends, with the House and the Senate poised to take up legislation to insure nearly all Americans (The New York Times).

Behind Scenes, President Obama Shepherds The Health Reform Bill As health care reform legislation inexorably makes its way through Congress, President Barack Obama, who has the biggest stake in its success, has seemed distant from the grueling, detailed work of crafting the reform law (Politico).

Health Care Plan Hits Rich With Big Tax Increases The typical family would be spared higher taxes from the House Democratic plan to overhaul health care, and their low-income neighbors could come out ahead (The Associated Press).

GOP Set To Propose Its Own Health Bill Republicans are preparing an alternative health-care bill to Democratic legislation, House Republican Leader John Boehner said, marking a shift in strategy as the full House is set to begin debate on the issue this week (The Wall Street Journal).

Health Insurance Mandate Alarms Some Among some libertarians and conservatives, the most troubling aspect of the pending healthcare reform bills is the prospect of a federal requirement that Americans buy insurance (Los Angeles Times).

A top-ranking GOP lawmaker is calling on Energy and Commerce Committee chairman Henry Waxman to convene a public hearing with key administration officials on Wednesday before the House votes on the healthcare bill (The Hill).

CBO Rebuts Pros, Cons Of Public Option A report issued by the nonpartisan Congressional Budget Office highlights faults with both sides of the argument to create a public health-insurance plan (The Wall Street Journal).

What's all the fuss about? After all the noise over Democrats' push for a government insurance plan to compete with private carriers, coverage numbers are finally in: Two percent (The Associated Press/The Washington Post).

Health Group To Monitor Safety Of Swine Flu Vaccine Independent health advisers will begin monitoring safety of the swine flu vaccine today, an extra step the government promised in this year's unprecedented program to watch for possible side effects (The Associated Press/The Boston Globe).

Sign up to receive this list of First Edition headlines via email. Check out all of Kaiser Health News' email options including First Edition and Breaking News alerts on our Subscriptions page. 


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Argonne receives $21.7 million to advance cancer and vaccine discoveries